Surviving Hodgkin's lymphoma: current treatment options | Dana-Farber Cancer Institute
3 Views
administrator
07/09/23
ABVD is the most common chemotherapy regimen used to treat Hodgkin's lymphoma. Dr. Andrea Ng from the Department of Radiation Oncology, Skin (Cutaneous) Cancer Treatment Center and Melanoma Treatment Center, describes the risks and side effects of chemotherapy and radiation, including possible damage to the heart muscle. Dr. Ng discusses the importance of smoking cessation, lipid screening, regular exercise, and a healthy diet in reducing the risk of future heart problems for cancer survivors. Find out more about survivorship at: http://www.dana-farber.org/For....-Adult-Cancer-Surviv
-
Category
Show more
Facebook Comments
No comments found